0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µþÀÇ ÀڱðæºÎ¾Ï ¿¹¹æ °ü·Ã HPV ¹é½ÅÁ¢Á¾¿¡ ´ëÇÑ ¾î¸Ó´Ï ¼ö¿ëµµ¿Í ¿µÇâ¿äÀÎ

Factors Influencing Mothers¡¯ Acceptance of Human Papillomavirus Vaccination to Prevent Cervical Cancer in their Daughters

¿©¼º°Ç°­°£È£ÇÐȸÁö 2011³â 17±Ç 2È£ p.137 ~ 147
KMID : 0606420110170020137
±èÇý¿ø ( Kim Hae-Won ) - °üµ¿´ëÇб³ °£È£Çаú

Abstract

Purpose: This study was done to examine mothers¡¯ acceptance and its influencing factors in daughters¡¯ human papillomavirus (HPV) vaccination to prevent cervical cancer.

Methods: From July 20 to August 31, 2010, 220 mothers of unmarried daughters responded to self-administered questionnaires about their acceptance of HPV vaccination for their daughters and the optimal age for HPV vaccination. Descriptive statistics, univariate logistic and multiple logistic regression were used for data analysis with SPSS/WIN 12.0.

Results: Mothers indicating their willingness to pay for their daughters to receive HPV vaccination accounted for 61.8%, and willingness with health insurance coverage, 84.5%. Mean optimal age for HPV vaccination was 19.78¡¾3.96) years. With self-payment the factor influencing mothers willingness was necessity of HPV vaccination (OR=30.45, 95% CI=10.33~89.15). With health insurance coverage, income (OR=3.02, 95% CI: 1.19~7.62), necessity of HPV vaccination (OR=15.05, 95% CI=4.15~54.64), concern about HPV vaccine safety (OR=2.99, 95% CI=1.15~7.76), and experience of Pap test (OR=3.16, 95% CI=1.24~8.05) were factors influencing mothers willingness. Other influencing factors were optimal age for HPV vaccination, knowing about HPV (OR=7.66, 95% CI=2.19~26.82), and age of youngest daughter (OR=3.95, 95% CI=1.34~11.68).

Conclusion: Financial support is anticipated for low income families in a primary approach to increase HPV vaccination. And focusing on earlier age and concerns about vaccination are necessary to gain mothers¡¯ acceptance.
KeyWords
ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º ¹é½Å, ÀڱðæºÎ¾Ï, ¾î¸Ó´Ï, ŵµ
Papillomavirus vaccines, Cervix cancer, Mothers, Attitude
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed